Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies

Hydroxamate-based histone deacetylase inhibitors (Hb-HDACIs), such as vorinostat, belinostat and panobinostat, have been previously shown to have a wide range of activity in hematologic malignancies such as cutaneous T-cell lymphoma and multiple myeloma. Recent data show that they synergize with a v...

Descripción completa

Detalles Bibliográficos
Autores principales: Grassadonia, Antonino, Cioffi, Pasquale, Simiele, Felice, Iezzi, Laura, Zilli, Marinella, Natoli, Clara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795372/
https://www.ncbi.nlm.nih.gov/pubmed/24202327
http://dx.doi.org/10.3390/cancers5030919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795372/
https://www.ncbi.nlm.nih.gov/pubmed/24202327
http://dx.doi.org/10.3390/cancers5030919

Ejemplares similares